XML 35 R21.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2024
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
Note 15 – Stock‑Based Compensation
 
Prior to June 21, 2023, the Company issued stock-based compensation awards to its directors and officers under the 2018 Long Term Incentive Plan (“LTIP”) which allowed the grant of non-qualified and incentive stock options, stock appreciation rights, full value awards and cash incentive awards.  The maximum number of shares that could be awarded under that plan was 161,639 shares.

On June 21, 2023, stockholders approved the Amended and Restated 2018 Long Term Incentive Plan (“Amended and Restated LTIP”) which allows the issuance of 487,500 additional shares and brought the number of shares that may be issued under the Amended and Restated LTIP to 649,139 shares.

The following table summarizes stock option activity during the year ended December 31, 2024:
 
   

 
   
Number
Outstanding
   
Weighted
Average
Exercise
Price
 
Outstanding at beginning of year
   
31,250
   
$
12.96
 
Granted during the year
   
     
 
Exercised during the year
   
     
 
Forfeited or expired during the year
   
(18,750
)
   
12.96
 
Outstanding at end of year
   
12,500
   
$
12.96
 
Exercisable at end of year
   
12,500
   
$
12.96
 
 
There was no stock-based compensation expense related to stock options during 2024 or 2023.


Options outstanding and exercisable at year‑end 2024 were as follows:
 
   
Outstanding
   
Exercisable
 
Grant Date
 
Number
Outstanding
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise
Price
   
Aggregate
Intrinsic
Value
   
Number
Outstanding
   
Weighted
Average
Exercise
Price
   
Aggregate
Intrinsic
Value
 
February 24, 2016
   
12,500
 

 
$
12.96
           
12,500
   
$
12.96
       
     
12,500
 
1.12 years
 
$
12.96
   
$
     
12,500
   
$
12.96
   
$
 

Stock Awards to Directors

In May 2024 and February 2023, the Company awarded 19,832 and 9,230 shares of common stock, respectively, to its directors under the LTIP, which are fully vested. The Company recorded $96 thousand and $95 thousand of compensation expense in the years ended December 31, 2024 and December 31, 2023, respectively, based on the fair value of the stock on the date of the award.

Restricted Stock Awards to Employees

In March 2022, the Company issued 61,908 shares of restricted stock to its officers and employees under the LTIP, of which 21,276 shares have been forfeited as of December 31, 2024. Each restricted stock award was valued based on the fair value of the stock on the date of the award. These awarded shares of restricted stock fully vest over periods ranging from 36 months to 60 months from their respective dates of grant. Stock-based compensation is recognized on a straight-line basis over the vesting period.  During 2024 and 2023, the Company recorded $88 thousand and $106 thousand, respectively, of stock-based compensation expense related to shares awarded to employees.

On June 21, 2023, the Company issued 92,720 shares of restricted stock to its officers and employees under the Amended and Restated LTIP, of which 23,997 shares have been forfeited as of December 31, 2024. Each restricted stock award was valued based on the fair value of the stock on the date of the award. These awarded shares of restricted stock fully vest over periods ranging from 36 months to 60 months from their respective dates of grant. Stock-based compensation is recognized on a straight-line basis over the vesting period. During the years ended December 31, 2024 and 2023, the Company recorded $113 thousand and $104 thousand, respectively, of stock-based compensation expense related to these restricted stock awards.

On March 26, 2024, and April 5, 2024, the Company issued 126,083 shares of restricted stock to its officers and employees under the Amended and Restated LTIP, of which 13,015 shares have been forfeited as of December 31, 2024. Each restricted stock award was valued based on the fair value of the stock on the date of the award. These awarded shares of restricted stock fully vest over periods ranging from 36 months to 60 months from their respective dates of grant.  Stock-based compensation is recognized on a straight-line basis over the vesting period. During the year ended December 31, 2024 the Company recorded $108 thousand of stock-based compensation expense related to these restricted stock awards.

As of December 31, 2024, 307,046 shares had been awarded under the Amended and Restated LTIP and 342,093 shares were available to be awarded.

A summary of restricted stock unit activity for the year ended December 31, 2024 is as follows:

    
Restricted Stock Units
(In thousands)
   
Weighted Average
Grant Date Fair Value
   
Remaining
Contractual Life
(months)
 
Unvested at December 31, 2023
   
113,568
    $
9.12
     
39
 
Granted during period
   
145,915
   

5.73
     
36
 
Vested during period
   
(44,560
)
   
     
 
Forfeited or expired during period
   
(30,049
)
   
     
 
Unvested at December 31, 2024
   
184,874
   
$
8.91
     
31
 

As of December 31, 2024, there was $1.6 million of total unrecognized equity-based compensation expense that the Company expects to recognize over the remaining contractual life.

All common stock share amounts above have been retroactively adjusted, as applicable, for the 1-for-8 reverse stock split effective November 1, 2023.  See Note 2.